Third Prize: Intermediate-Term Outcomes After Renal Cryoablation: Results of a Multi-Institutional Study

Abstract

CA of renal masses results in acceptable oncologic efficacy accompanied by a tolerable complication profile in a cohort with a mean follow-up of 27.4 months. CA remains a viable treatment option for small renal masses in selected patients.